Key points from article :
Non-profit Betterhumans known for its work in the transhumanist community announced its intention to begin small-scale trials of senolytic therapies.
The aim is to remove toxic senescent cells from the body in a bid to address age-related diseases.
The organization found out that combination of dasatinib and quercetin, has enjoyed success in mice in a number of studies. It improved mouse health and, in some cases, even increased lifespan.
The pilot studies aim to find out whether it will have the same positive results to humans.
